DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Brufsky A, Valero V, Tiango B. et al.
Second-line bevacizumab-containing therapy in patients with triple-negative breast cancer: subgroup analysis of the RIBBON-2 trial.
Breast Cancer Res Treat 2012;
133: 1067-1075
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.